Nvigen

nvigen logoNVIGEN is a nanotechnology empowered personalized medicine innovator.
Our pipeline of visionary solutions stems from our innovative nanomedicine platform. We are focusing on the development of a comprehensive circulating bio-marker biopsy technology, NVIGEN X™, to predict cancer recurrence at the earliest possible time and guide the most effective personalized therapy.

NVIGEN X™ is enabled by the state-of-the-art molecularly engineered nanoparticles, MagVigen™ and MyQuVigen™, to efficiently capture and identify molecular information from proteins, cells and nucleic acids. We are developing NVIGEN X™ into accurate, automated and FDA approved clinical instruments and reagent kits deployable at hundreds and thousands of hospitals, turning fatal cancers into manageable diseases.

www.nivgen.com

More information?Contact Us by e-mail

MyQuVigen™ – SH surface, 535, 585, 615 or 635 nm emission 41001 - 1ml

€ 476,52